ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.910,43
-0,01%
S&P 500
6.083,57
0,36%
Dow Jones
44.747,63
-0,28%
Euro vs US Dollar
1,0385
0,00%
Bitcoin
97.330,62
0,78%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. 10x Genomics Inc (TXG) Börsenkurse

10x Genomics Inc

10x Genomics Inc (TXG)

Terex Corp.
Torex Gold Resources Inc
14,65
-0,05
(-0,34%)
Geschlossen 07 Februar 10:00PM
Verzögert um 15 Minuten
14,75
0,10
( 0,68% )
Vor Marktöffnung: 10:40AM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
14,75
Gebot
14,78
Fragen
15,05
Volumen
1.031
0,00 Tagesbereich 0,00
12,95 52-Wochen-Bereich 51,2199
Marktkapitalisierung
1,786B
Handelsende
14,65
Handelsbeginn
-
Letzte Trade
30
@
14.96
Letzter Handelszeitpunkt
11:24:11
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.884.482
Ausgegebene Aktien
121.054.448
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-6,95
Gewinn pro Aktie (EPS)
-2,11
Erlöse
618,73M
Nettogewinn
-255,1M

Über 10x Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics S... 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables. Mehr anzeigen

Sektor
Lab Analytical Instruments
Branche
Lab Analytical Instruments
Website
www.10xgenomics.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
10x Genomics Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TXG. The last closing price for 10x Genomics was US$14,65. Over the last year, 10x Genomics shares have traded in a share price range of US$ 12,95 to US$ 51,2199.

10x Genomics currently has 121.054.448 shares in issue. The market capitalisation of 10x Genomics is US$1,77 billion. 10x Genomics has a price to earnings ratio (PE ratio) of -6.95.

TXG Neueste Nachrichten

Weitere Nachrichten

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology PR Newswire REDWOOD CITY, Calif., Feb. 6, 2025 Landmark single-cell...

21 Stunden vor
PR Newswire (US)

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025 PR Newswire PLEASANTON, Calif., Jan. 28, 2025 PLEASANTON, Calif., Jan. 28, 2025 /PRNewswire/ -- 10x...

28 Januar 2025
PR Newswire (US)

Form 8-K - Current report

13 Januar 2025
Edgar (US Regulatory)

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire PLEASANTON, Calif., Jan. 2, 2025 PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ -- 10x Genomics...

02 Januar 2025
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

24 Dezember 2024
Edgar (US Regulatory)

U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products

U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products PR Newswire PLEASANTON, Calif., Dec. 23, 2024 PLEASANTON...

23 Dezember 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

25 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 November 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 November 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.43-2.8326745718115.1815.514.01213293314.65057928CS
4-0.72-4.6541693600515.4717.2513.76199155215.09047883CS
120.74.9822064056914.0517.2512.95188448214.87123426CS
26-4.43-23.096976016719.1824.7612.95185239117.0515541CS
52-31.03-67.780690257845.7851.219912.95176463822.25211753CS
156-75.59-83.672791675990.3499.1412.95137901436.73361921CS
260-77.95-84.088457389492.7208.9912.95112763363.45696499CS

TXG - Frequently Asked Questions (FAQ)

What is the current 10x Genomics share price?
The current share price of 10x Genomics is US$ 14,75
How many 10x Genomics shares are in issue?
10x Genomics has 121.054.448 shares in issue
What is the market cap of 10x Genomics?
The market capitalisation of 10x Genomics is USD 1,77B
What is the 1 year trading range for 10x Genomics share price?
10x Genomics has traded in the range of US$ 12,95 to US$ 51,2199 during the past year
What is the PE ratio of 10x Genomics?
The price to earnings ratio of 10x Genomics is -6,95
What is the cash to sales ratio of 10x Genomics?
The cash to sales ratio of 10x Genomics is 2,87
What is the reporting currency for 10x Genomics?
10x Genomics reports financial results in USD
What is the latest annual turnover for 10x Genomics?
The latest annual turnover of 10x Genomics is USD 618,73M
What is the latest annual profit for 10x Genomics?
The latest annual profit of 10x Genomics is USD -255,1M
What is the registered address of 10x Genomics?
The registered address for 10x Genomics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the 10x Genomics website address?
The website address for 10x Genomics is www.10xgenomics.com
Which industry sector does 10x Genomics operate in?
10x Genomics operates in the LAB ANALYTICAL INSTRUMENTS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RANDRand Capital Corporation
US$ 36,74
(59,67%)
7
ZOOZZOOZ Power Ltd
US$ 3,22
(56,31%)
46
LCNBLCNB Corporation
US$ 23,99
(53,00%)
7
MGOLMGO Global Inc
US$ 0,2803
(51,51%)
26,01M
SERASera Prognostics Inc
US$ 6,99
(48,41%)
1
BTMDBiote Corporation
US$ 2,07
(-56,96%)
22
GDSTGoldenstone Acquisition Ltd
US$ 5,00
(-56,56%)
201
ANIKAnika Therapeutics Inc
US$ 8,00
(-55,03%)
20
BKHABlack Hawk Acquisition Corporation
US$ 5,015
(-52,12%)
205
EDRYEuroDry Ltd
US$ 6,01
(-45,01%)
4
UPCUniverse Pharmaceuticals Inc
US$ 0,23
(42,86%)
28,33M
MGOLMGO Global Inc
US$ 0,2808
(51,78%)
26,01M
NIVFNewGenIvf Group Ltd
US$ 0,2035
(31,21%)
17,29M
CYNCYNGN Inc
US$ 0,0625
(-26,12%)
8,66M
LTRYLottery com Inc
US$ 1,88
(33,33%)
7,69M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
TXG
10x Genomics
BIT
S32512
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten